SonoScape Medical Corp. (SHE:300633)

Market Cap	8.39B -37.4%
Revenue (ttm)	2.36B +20.1%
Net Income	177.60M +253.2%
EPS	0.41 +255.5%
Shares Out	430.32M
PE Ratio	47.13
Forward PE	28.22
Dividend	0.18 (0.90%)
Ex-Dividend Date	Jun 5, 2026

Volume	3,271,830
Open	20.99
Previous Close	19.91
Day's Range	19.34 - 20.99
52-Week Range	19.40 - 37.73
Beta	-0.32
Analysts	Buy
Price Target	34.28 (+75.8%)
Earnings Date	Aug 25, 2026

About SonoScape Medical

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surgery soluti...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 3,133
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300633

Financial Performance

In 2025, SonoScape Medical's revenue was 2.31 billion, an increase of 14.65% compared to the previous year's 2.01 billion. Earnings were 197.28 million, an increase of 38.54%.